To extend the above findings to tumor-induced models (after tumor injection), B16 melanoma or LLC cells were subcutaneously injected into the flank sites of Lal+/+ recipient mice in both syngeneic C57BL/6 and allogeneic FVB/N genetic backgrounds for 14 days. The gene discussed is LIPA; the disease is melanoma.